Vitreoretinal Surgery Fellowship:
Associated Retinal Consultants, P.C., William Beaumont Hospital, Royal Oak, MI
University of Southern California, USC Roski Eye Institute, LAC+USC Medical Center, Children’s Hospital Los Angeles, CA
MetroWest Medical Center, Framingham, MA
University of Miami Miller School of Medicine, Miami, FL
University of Florida, Gainesville, FL
Stavros N. Moysidis, M.D., is a Pediatric & Adult Retina Specialist. He received his vitreoretinal surgery fellowship training at Associated Retinal Consultants / Beaumont, where he had the privilege of caring for premature infants and children who traveled with their families from around the world to receive care. His clinical and research interests include retinopathy of prematurity, Coats’ disease, familial exudative vitreoretinopathy, persistent fetal vasculature, diabetic retinopathy, macular holes, retinal detachments, proliferative vitreoretinopathy, and ocular trauma. Dr. Moysidis received his ophthalmology residency training at the LAC+USC Medical Center, USC Roski Eye Institute, and Children’s Hospital Los Angeles (CHLA), and his medical education at the University of Miami. At the Bascom Palmer Eye Institute, he developed a novel, minimally invasive, nanoparticle-based, cell delivery system for the magnetic transplantation of human tissue, which is now in clinical trials. Dr. Moysidis has received numerous prestigious honors, including the Ronald G. Michels Fellowship, the Heed Fellowship, the Dr. Alving Endowed Biomedical Research Award, and the Lombardi Scholarship. He has published over 30 peer-reviewed manuscripts and book chapters in internationally esteemed journals, including Proceedings of the National Academy of Sciences (PNAS), Nanomedicine, Ophthalmology, Retina, and Investigative Ophthalmology & Visual Science (IOVS). Dr. Moysidis is fluent in Spanish and Greek, and he enjoys collaborating on interdisciplinary teams to deliver the highest quality of care to patients of all ages.
Vitreoretinal Surgery Fellowship:
University of Southern California, USC Roski Eye Institute, LAC+USC Medical Center, Children’s Hospital Los Angeles, Retina-Vitreous Associates Medical Group, Los Angeles, CA
University of Southern California, USC Roski Eye Institute, LAC+USC Medical Center, Children’s Hospital Los Angeles, Los Angeles, CA
William Beaumont Hospital, Royal Oak, Michigan
University of Massachusetts Medical School, Worcester, MA
Massachusetts Institute of Technology, Cambridge, MA
Nicole Koulisis, M.D., graduated from the Massachusetts Institute of Technology with two Bachelor of Science degrees in Biology and Spanish, after graduating Valedictorian of her high school. She pursued her medical training at the University of Massachusetts Medical School and her internship at William Beaumont Hospital in Royal Oak, Michigan. She completed Ophthalmology residency training at the University of Southern California. Dr. Koulisis is completing her two-year Vitreoretinal Surgery fellowship at the USC Roski Eye Institute, LAC+USC Medical Center, Children’s Hospital Los Angeles, and Retina-Vitreous Associates Medical Group, where she cares for patients with an array of ophthalmic conditions, including complex retinal detachments, ocular trauma, dislocated intraocular lenses, and other sight-threatening conditions. She has published over 35 peer-reviewed manuscripts in distinguished journals including Nature, Ophthalmology, American Journal of Ophthalmology (AJO), and Investigative Ophthalmology & Visual Science (IOVS). Dr. Koulisis has received the prestigious Heed Fellowship, and has presented her research at esteemed meetings including the American Academy of Ophthalmology and Retina Society on varied topics, including wet macular degeneration, retinal vein occlusions, autologous retinal transplantation, familial exudative vitreoretinopathy, and ocular trauma. She has an interest in translational research and novel imaging modalities, and developing new therapies, surgical instruments, and devices to improve patients’ vision and function. Dr. Koulisis is fluent in Spanish and Greek, and she will be available to provide the highest quality of care to our patients at Retina Los Angeles beginning this summer.